INSPIRE MEDICAL SYSTEMS INCINSP
ASignal's systematic analysis rates INSP as Neutral.
Reflects the latest available analysis · analyzed Sep 13, 2026
The case on INSP
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health with debt-to-equity ratio of 0.04x
- High gross margin of 86.13% indicating pricing power
- Free cash flow of $94.64M supports operational resilience
- Current ratio of 8.55x reflects strong liquidity position
- Return on equity of 17.97% exceeds threshold for capital efficiency
- RSI at 74.34 indicates overbought conditions
- Negative revenue growth of -7.60% year-over-year
- Operating margin negative at -0.26%
- Forward P/E of 47.50x suggests high valuation relative to current earnings
- No Reddit mentions, indicating low retail investor interest or engagement
See the full verdict on INSP
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes INSP
Most investors never get a second opinion, let alone several. ASignal runs INSP past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.